China National Accord Medicines Corporation Ltd. (SHE:200028)
China
· Delayed Price · Currency is CNY · Price in HKD 12.95
+0.02 (0.15%)
Jul 11, 2025, 3:04 PM CST
SHE:200028 Revenue
China National Accord Medicines Corporation had revenue of 18.29B CNY in the quarter ending March 31, 2025, a decrease of -4.17%. This brings the company's revenue in the last twelve months to 73.58B, down -3.03% year-over-year. In the year 2024, China National Accord Medicines Corporation had annual revenue of 74.38B, down -1.46%.
Revenue (ttm)
73.58B
Revenue Growth
-3.03%
P/S Ratio
0.18
Revenue / Employee
1.87M
Employees
39,449
Market Cap
13.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 74.38B | -1.10B | -1.46% |
| Dec 31, 2023 | 75.48B | 2.03B | 2.77% |
| Dec 31, 2022 | 73.44B | 5.09B | 7.44% |
| Dec 31, 2021 | 68.36B | 8.71B | 14.60% |
| Dec 31, 2020 | 59.65B | 6.86B | 13.00% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |